Variations in hospitalisation costs for acute myocardial infarction - a comparison across Europe

Health Economics
Oliver Tiemann

Abstract

The aim of this study was to determine whether between-country variations in hospital costs are larger than within-country variations and, furthermore, to explore reasons for this variability. For this purpose, we chose the primary treatment of patients with acute myocardial infarction (AMI) as an episode of care. We obtained hospitalisation costs and reimbursement rates from 45 hospitals in nine different EU member states (i.e. Denmark, England, France, Germany, Hungary, Italy, Netherlands, Poland, and Spain) for the year 2005. To further analyse the variations in hospital costs, we employed a hierarchical random effects model based on treatment and hospital characteristics and using purchasing power parities (PPPs) as a proxy for country-specific price levels. The between-country standard error was estimated at 2473 euros, whereas the within-country standard error was estimated at 1242 euros. Our regression analysis showed that percutaneous coronary intervention was associated with significantly increased hospitals costs compared to other treatment strategies. We were able to distinguish between three groups of countries with different cost levels based on the number of hospitals that were able to provide these services (i.e....Continue Reading

References

Mar 1, 1996·Health Economics·T JeffersonV Demicheli
Sep 28, 1998·JAMA : the Journal of the American Medical Association·R MechanicA Dobson
Nov 2, 1999·Health Economics·G López-Casasnovas, M Saez
Feb 1, 2003·European Heart Journal·Frans Van de WerfUNKNOWN Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology
Feb 24, 2004·Health Care Management Science·Michael D Rosko
Sep 24, 2004·Health Economics·Brigitte Dormont, Carine Milcent
Dec 22, 2005·Current Medical Research and Opinion·Lida R Etemad, Patrick L McCollam
Aug 29, 2006·Surgery·Justin B Dimick, Samuel R G Finlayson
Oct 5, 2006·Health Care Management Science·Fernando Sánchez-MartínezJaume Puig-Junoy
Oct 5, 2006·Health Care Management Science·David Epstein, Anne Mason
Oct 5, 2006·Health Care Management Science·Jonas SchreyöggReinhard Busse
Oct 13, 2006·Health Economics·Edward EvansEun-Hwan Oh
Nov 14, 2006·Current Problems in Cardiology·Eric H YangBernard J Gersh
Nov 23, 2006·Journal of the American College of Surgeons·Michael VanBibberSamuel R G Finlayson

❮ Previous
Next ❯

Citations

Jan 13, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·M PirsonP Leclercq
Mar 5, 2013·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·R R SoekhlalS S Tan
Jun 15, 2014·BMC Cardiovascular Disorders·Anil VaidyaErik A L Biessen
Jun 6, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Anna RingborgPeter Lindgren
Jan 3, 2013·European Journal of Clinical Investigation·Karin WildiChristian Mueller
Jul 27, 2011·The American Journal of Medicine·Philip HaafChristian Mueller
Jan 18, 2015·European Journal of Epidemiology·Taulant MukaOscar H Franco
Dec 4, 2012·International Journal of Cardiology·Philip HaafChristian Mueller
Aug 6, 2013·International Journal of Cardiology·Karin WildiChristian Mueller
Nov 5, 2017·Circulation·Raphael TwerenboldChristian Mueller
Jan 24, 2009·Stroke; a Journal of Cerebral Circulation·Mohammad WasayAyeesha Kamal
Dec 7, 2017·Health Economics Review·Mads D FaurbyDespena Andrioti
Mar 16, 2018·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Narjeet S KhurmiAmit K Mathur
Jul 29, 2010·Aging Clinical and Experimental Research·Prisco PiscitelliAlessandro Distante

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.